Żaczek, M., Weber-Dąbrowska, B., Międzybrodzki, R., Łusiak-Szelachowska, M. & Górski, A. Phage therapy in Poland—a centennial journey to the first ethically approved treatment facility in Europe. Front. Microbiol. 11, 1056 (2020).
Antimicrobial Resistance CollaboratorsGlobal burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).
O’Neill, J. Tackling drug-resistant infections globally: final report and recommendations. In The Review on Antimicrobial Resistance. (Government of the United Kingdom, 2016).
Chan, B. K., Stanley, G., Modak, M., Koff, J. L. & Turner, P. E. Bacteriophage therapy for infections in CF. Pediatr. Pulmonol. 56, S4–S9 (2021).
Schooley, R. T. et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 61, e00954-17 (2017).
Strathdee, S. A., Hatfull, G. F., Mutalik, V. K. & Schooley, R. T. Phage therapy: from biological mechanisms to future directions. Cell 186, 17–31 (2023).
Gencay, Y. E. et al. Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice. Nat. Biotechnol. 42, 265–274 (2024).
Dedrick, R. M. et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat. Med. 25, 730–733 (2019).
Mahler, M., Costa, A. R., van Beljouw, S. P. B., Fineran, P. C. & Brouns, S. J. J.Approaches for bacteriophage genome engineering. Trends Biotechnol. 41, 669–685 (2023).
Kiro, R., Shitrit, D. & Qimron, U. Efficient engineering of a bacteriophage genome using the type I-E CRISPR–Cas system. RNA Biol. 11, 42–44 (2014).
Box, A. M., McGuffie, M. J., O’Hara, B. J. & Seed, K. D. Functional analysis of bacteriophage immunity through a type I-E CRISPR–Cas system in Vibrio cholerae and its application in bacteriophage genome engineering. J. Bacteriol. 198, 578–590 (2016).
Bari, S. M. N., Walker, F. C., Cater, K., Aslan, B. & Hatoum-Aslan, A. Strategies for editing virulent staphylococcal phages using CRISPR–Cas10. ACS Synth. Biol. 6, 2316–2325 (2017).
Ramirez-Chamorro, L., Boulanger, P. & Rossier, O. Strategies for bacteriophage T5 mutagenesis: expanding the toolbox for phage genome engineering. Front. Microbiol. 12, 667332 (2021).
Adler, B. A. et al. Broad-spectrum CRISPR–Cas13a enables efficient phage genome editing. Nat. Microbiol. 7, 1967–1979 (2022).
Strotskaya, A. et al. The action of Escherichia coli CRISPR–Cas system on lytic bacteriophages with different lifestyles and development strategies. Nucleic Acids Res. 45, 1946–1957 (2017).
Ando, H., Lemire, S., Pires, D. P. & Lu, T. K. Engineering modular viral scaffolds for targeted bacterial population editing. Cell Syst. 1, 187–196 (2015).
Nozaki, S. Rapid and accurate assembly of large DNA assisted by in vitro packaging of bacteriophage. ACS Synth. Biol. 11, 4113–4122 (2022).
Emslander, Q. et al. Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria. Cell Chem. Biol. 29, 1434–1445 (2022).
Farzadfard, F. & Lu, T. K. Genomically encoded analog memory with precise in vivo DNA writing in living cell populations. Science 346, 1256272 (2014).
Schubert, M. G. et al. High-throughput functional variant screens via in vivo production of single-stranded DNA. Proc. Natl Acad. Sci. USA 118, e2018181118 (2021).
Simon, A. J., Morrow, B. R. & Ellington, A. D. Retroelement-based genome editing and evolution. ACS Synth. Biol. 7, 2600–2611 (2018).
Lopez, S. C., Crawford, K. D., Lear, S. K., Bhattarai-Kline, S. & Shipman, S. L. Precise genome editing across kingdoms of life using retron-derived DNA. Nat. Chem. Biol. 18, 199–206 (2022).
Bobonis, J. et al. Bacterial retrons encode phage-defending tripartite toxin–antitoxin systems. Nature 609, 144–150 (2022).
Millman, A. et al. Bacterial retrons function in anti-phage defense. Cell 183, 1551–1561 (2020).
Palka, C., Fishman, C. B., Bhattarai-Kline, S., Myers, S. A. & Shipman, S. L. Retron reverse transcriptase termination and phage defense are dependent on host RNase H1. Nucleic Acids Res. 50, 3490–3504 (2022).
Gao, L. et al. Diverse enzymatic activities mediate antiviral immunity in prokaryotes. Science 369, 1077–1084 (2020).
Mosberg, J. A., Lajoie, M. J. & Church, G. M. Lambda red recombineering in Escherichia coli occurs through a fully single-stranded intermediate. Genetics 186, 791–799 (2010).
Nyerges, Á. et al. A highly precise and portable genome engineering method allows comparison of mutational effects across bacterial species. Proc. Natl Acad. Sci. USA 113, 2502–2507 (2016).
Wannier, T. M. et al. Improved bacterial recombineering by parallelized protein discovery. Proc. Natl Acad. Sci. USA 117, 13689–13698 (2020).
Nyerges, Á. et al. Conditional DNA repair mutants enable highly precise genome engineering. Nucleic Acids Res. 42, e62 (2014).
Bhattarai-Kline, S. et al. Recording gene expression order in DNA by CRISPR addition of retron barcodes. Nature 608, 217–225 (2022).
Aronshtam, A. & Marinus, M. G. Dominant negative mutator mutations in the mutL gene of Escherichia coli. Nucleic Acids Res. 24, 2498–2504 (1996).
Ellis, H. M., Yu, D., DiTizio, T. & Court, D. L. High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides. Proc. Natl Acad. Sci. USA 98, 6742–6746 (2001).
Weigele, P. & Raleigh, E. A. Biosynthesis and function of modified bases in bacteria and their viruses. Chem. Rev. 116, 12655–12687 (2016).
Bryson, A. L. et al. Covalent modification of bacteriophage T4 DNA inhibits CRISPR–Cas9. mBio 6, e00648 (2015).
Fleischman, R. A., Cambell, J. L. & Richardson, C. C. Modification and restriction of T-even bacteriophages. In vitro degradation of deoxyribonucleic acid containing 5-hydroxymethylctosine. J. Biol. Chem. 251, 1561–1570 (1976).
Weigel, C. & Seitz, H. Bacteriophage replication modules. FEMS Microbiol. Rev. 30, 321–381 (2006).
Wolfson, J., Dressler, D. & Magazin, M. Bacteriophage T7 DNA replication: a linear replicating intermediate (gradient centrifugation–electron microscopy–E. coli–DNA partial denaturation). Proc. Natl Acad. Sci. USA 69, 499–504 (1972).
Bourguignon, G. J., Sweeney, T. K. & Delius, H. Multiple origins and circular structures in replicating T5 bacteriophage DNA. J. Virol. 18, 245–259 (1976).
Hochschild, A. & Lewis, M. The bacteriophage lambda CI protein finds an asymmetric solution. Curr. Opin. Struct. Biol. 19, 79–86 (2009).
Tal, A., Arbel-Goren, R., Costantino, N., Court, D. L. & Stavans, J. Location of the unique integration site on an Escherichia coli chromosome by bacteriophage lambda DNA in vivo. Proc. Natl Acad. Sci. USA 111, 7308–7312 (2014).
Filsinger, G. T. et al. Characterizing the portability of phage-encoded homologous recombination proteins. Nat. Chem. Biol. 17, 394–402 (2021).
Hernandez, A. J. & Richardson, C. C. Gp2.5, the multifunctional bacteriophage T7 single-stranded DNA binding protein. Semin. Cell Dev. Biol. 86, 92–101 (2019).
Werten, S. Identification of the ssDNA-binding protein of bacteriophage T5: implications for T5 replication. Bacteriophage 3, e27304 (2013).
Maffei, E. et al. Systematic exploration of Escherichia coli phage–host interactions with the BASEL phage collection. PLoS Biol. 19, e3001424 (2021).
Marinelli, L. J. et al. BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes. PLoS ONE 3, e3957 (2008).
Mosberg, J. A., Gregg, C. J., Lajoie, M. J., Wang, H. H. & Church, G. M. Improving lambda red genome engineering in Escherichia coli via rational removal of endogenous nucleases. PLoS ONE 7, e44638 (2012).
Huss, P., Meger, A., Leander, M., Nishikawa, K. & Raman, S.Mapping the functional landscape of the receptor binding domain of T7 bacteriophage by deep mutational scanning. eLife 10, e63775 (2021).
Parson, K. A. & Snustad, D. P. Host DNA degradation after infection of Escherichia coli with bacteriophage T4: dependence of the alternate pathway of degradation which occurs in the absence of both T4 endonuclease II and nuclear disruption on T4 endonuclease IV. J. Virol. 15, 221–224 (1975).
Warner, H. R., Drong, R. F. & Berget, S. M. Early events after infection of Escherichia coli by bacteriophage T5. Induction of a 5′-nucleotidase activity and excretion of free bases. J. Virol. 15, 273–280 (1975).
Dunne, M. et al. Reprogramming bacteriophage host range through structure-guided design of chimeric receptor binding proteins. Cell Rep. 29, 1336–1350 (2019).
Yehl, K. et al. Engineering phage host-range and suppressing bacterial resistance through phage tail fiber mutagenesis. Cell 179, 459–469 (2019).
Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640–6645 (2000).
Jeong, H., Kim, H. J. & Lee, S. J.Complete genome sequence of Escherichia coli strain BL21. Genome Announc. 3, e00134-15 (2015).
Baba, T. et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2, 2006.0008 (2006).
Doron, S. et al. Systematic discovery of antiphage defense systems in the microbial pangenome. Science 359, eaar4120 (2018).
Fortier, L. C. & Moineau, S. Phage production and maintenance of stocks, including expected stock lifetimes. Methods Mol. Biol. 501, 203–219 (2009).
Kropinski, A. M., Mazzocco, A., Waddell, T. E., Lingohr, E. & Johnson, R. P. Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol. Biol. 501, 69–76 (2009).
Rajagopala, S. V., Casjens, S. & Uetz, P. The protein interaction map of bacteriophage lambda. BMC Microbiol. 11, 213 (2011).
Epp, C., Pearson, M. L. & Enquist, L. Downstream regulation of int gene expression by the b2 region in phage lambda. Gene 13, 327–337 (1981).
Mazzocco, A., Waddell, T. E., Lingohr, E. & Johnson, R. P. Enumeration of bacteriophages using the small drop plaque assay system. Methods Mol. Biol. 501, 81–85 (2009).
